Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q1 2018 Earnings

8MayExpected

Q2 2017

Q3 2017

Q4 2017

Q1 2018

-12.25

-8.31

-4.38

-0.44

Details

Expected EPS

-0.44

Actual EPS

-12.25

Surprise EPS

-11.81

Surprise Percent

+2,684.09%

Description

Spyre Therapeutics (SYRE) has reported earnings of -12.25 per share for Q1 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.